Understanding the Impact of Approved but Unfunded Vaccine Status on Parental Acceptance of an Adjuvanted Seasonal Influenza Vaccine for Infants: Results from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)–III

Understanding the Impact of Approved but Unfunded Vaccine Status on Parental Acceptance of an Adjuvanted Seasonal Influenza Vaccine for Infants: Results from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)–III

The adjuvanted trivalent influenza vaccine (aTIV) provides enhanced protection against influenza for infants but is not publicly funded (NPF). The objective of this prospective cohort study of parents with children 6 through 23 months of age was to understand how NPF status influences parental perce...

Full description

Bibliographic Details
Main Authors: William A. Fisher, Vladimir Gilca, Michelle Murti, Alison Orth, Hartley Garfield, Paul Roumeliotis, Emmanouil Rampakakis, Vivien Brown, John Yaremko, Paul Van Buynder, Constantina Boikos, James A. Mansi
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Vaccines
Subjects:
approved vaccine
unfunded vaccine
parental acceptance
vaccine hesitancy
influenza
Online Access:https://www.mdpi.com/2076-393X/10/10/1769

Internet

https://www.mdpi.com/2076-393X/10/10/1769

Similar Items